Cardiac structure and function in patients with schizophrenia taking antipsychotic drugs: an MRI study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2158-3188
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cardiac structure and function in patients with schizophrenia taking antipsychotic drugs: an MRI study ; volume:9 ; number:1 ; day:7 ; month:6 ; year:2019 ; pages:1-10 ; date:12.2019
Translational Psychiatry ; 9, Heft 1 (7.6.2019), 1-10, 12.2019
- Creator
-
Pillinger, Toby
Osimo, Emanuele F.
Marvao, Antonio de
Berry, Ms Alaine
Whitehurst, Thomas
Statton, Ben
Quinlan, Marina
Brugger, Stefan
Vazir, Ali
Cook, Stuart A.
O’Regan, Declan P.
Howes, Oliver D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-019-0502-x
- URN
-
urn:nbn:de:101:1-2019102123185859701117
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pillinger, Toby
- Osimo, Emanuele F.
- Marvao, Antonio de
- Berry, Ms Alaine
- Whitehurst, Thomas
- Statton, Ben
- Quinlan, Marina
- Brugger, Stefan
- Vazir, Ali
- Cook, Stuart A.
- O’Regan, Declan P.
- Howes, Oliver D.
- SpringerLink (Online service)
Other Objects (12)
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Updated rationale for the initial antipsychotic selection for patients with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
A thematic analysis assessing clinical decision-making in antipsychotic prescribing for schizophrenia
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Updated rationale for the initial antipsychotic selection for patients with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
A thematic analysis assessing clinical decision-making in antipsychotic prescribing for schizophrenia
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Updated rationale for the initial antipsychotic selection for patients with schizophrenia
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns